𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression

✍ Scribed by Michael K. Cohen; Daniel A. Arber; K. Scott Coffield; Gerald T. Keegan; Joseph McClintock; V. O. Speights Jr.


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
582 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Evaluation and clinical value of neuroen
✍ Cussenot, Olivier; Villette, Jean-Marie; Cochand-Priollet, Beatrix; Berthon, Phi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 2 views

## BACKGROUND. Prostate cancer, like other solid tumors, is a rather heterogeneous entity. More than 50% of all malignant prostatic tumors contain neuroendocrine-like cells, which cannot be attributed to small cell prostatic carcinoma or carcinoid-like tumors, which represent only 1-2% of all prost

Identification of differentially express
✍ Jeremy L. Goodin; Charles L. Rutherford πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 273 KB

## Abstract The LNCaP cell line is a versatile and useful model suitable for the study of human prostate cancer in vitro. It has been determined that the elevation of LNCaP intracellular cyclic adenosine monophosphate (cAMP) levels through the addition of membrane‐permeable cAMP analogs, phosphodie

Immunoreactivity for prostate-specific a
✍ Sauvageot, Jurgita; Epstein, Jonathan I. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 33 KB πŸ‘ 2 views

## Background: Although, in general, immunoperoxidase staining for prostate-specific antigen (psa) and prostate-specific acid phosphatase (psap) cannot distinguish between benign and malignant prostatic epithelium, immunoreactivity of these antigens may be helpful in predicting prognosis of prostat